Frédéric Chevallier is a partner at McDermott Will & Emery. Frédéric received his diploma in Law from University of Paris II Panthéon-Assas. He focuses his practice on intellectual property matters, and in particular brings extensive experience leading on cross-border patent patent litigation before the Unified Patent Court (UPC) as well as before French courts. He represents pharmaceutical innovators and high-tech companies in their complex multi-jurisdictional patent disputes including matters involving small molecules, antibodies, Supplementary Protection Certificates (SPCs), medical use claims, and standard essential patents. He represents clients in infringement and validity proceedings before several central local and regional divisions of the Unified Patent Court, as well as before French courts, in the life sciences and technology, media, and telecommunications (TMT) industries. His practice also encompasses trademark and copyright litigation, as well as transactional regulatory experience in the life sciences industry.